TNFSF11 and Miyoshi myopathy: HGF acting in concert with RANKL has been shown to promote osteoclast differentiation, while HGF acting alone did not affect osteoclast formation and suppressed osteoblastogenesis, thereby contributing to MM-induced bone disease [27,28].